Citius Oncology Inc (CTOR) Stock Price, Quote, News & History

CTORNASDAQ
$0.9400
0.01091.17%
At close: Sep 8, 5:00 PM EST
$0.9400
0.01091.17%
Pre-Market: 4:18 AM EST

Citius Oncology (CTOR) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-19.39M
Investing Cash Flow (TTM)
-12.75M
Financing Cash Flow (TTM)
48.70M
Free Cash Flow (TTM)
-32.14M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$93.06M
PE Ratio (TTM)
-
PE Ratio (FWD)
9.40
PEG Ratio (TTM)
-
PS Ratio (TTM)
12.36
PB Ratio (TTM)
2.46
Earnings Yield % (TTM)
-51.06%
Earnings Yield % (FWD)
10.64%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.38

Company Debt

Total Debt
$10.21M
LT Debt
$10.21M
LT Debt Issuance (TTM)
$9.64M
LT Debt Repayment (TTM)
-
Total Cash
$16.56M
Debt to Equity
0.25
Issuance of Debt (TTM)
$9.64M
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$0.94
Volume / Avg.
1.00 / 78.73K
Day Range
- - -
52 Wk Range
0.49 - 2.25
Market Cap
$99.41M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
70
Short Interest
1.53%
Days to Cover
2.32

About

Sector
Health Care
Industry
Biotechnology
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and compet...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Citius Oncology (CTOR) stock?

A

You can purchase shares of Citius Oncology (NASDAQ:CTOR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Citius Oncology (CTOR) competitors?

Q

What is the forecast, or price target, for Citius Oncology (CTOR) stock?

A

Citius Oncology has a consensus price target of $6.00.

Q

What is the current price for Citius Oncology (CTOR)?

A

The stock price for Citius Oncology (NASDAQ: CTOR) is $0.94 last updated September 9, 2026 at 7:14 PM EDT.

Q

Does Citius Oncology (CTOR) pay a dividend?

A

There are no upcoming dividends for Citius Oncology.

Q

When is Citius Oncology (NASDAQ:CTOR) reporting earnings?

A

Citius Oncology does not have any upcoming earnings scheduled.

Q

Is Citius Oncology (CTOR) going to split?

A

There is no upcoming split for Citius Oncology.

Q

What sector and industry does Citius Oncology (CTOR) operate in?

A

Citius Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.